Related Experiment Video
Updated: Feb 13, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
Published on: November 5, 2012
From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation
Kent W Mouw1, Panagiotis A Konstantinopoulos2
1Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.
Abstract:
Multiple clinical studies have revealed a link between genomic instability and response to anti-PD-1/PD-L1 therapy in cancer management. A recent study has revealed an important role for the ATR/Chk1 DNA damage checkpoint in regulating PD-L1 expression, raising important clinical and translational questions for therapy selection and study design.
Insights
Genomic instability impacts anti-PD-1/PD-L1 therapy response. The ATR/Chk1 DNA damage pathway regulates PD-L1 expression, offering new avenues for cancer treatment selection and study design.
Area of Science:
- Oncology
- Cancer Immunology
- Molecular Biology
Background:
- Genomic instability is linked to patient response to immune checkpoint inhibitors like anti-PD-1/PD-L1 therapy.
- The precise mechanisms underlying this link are under investigation.
- Understanding these mechanisms is crucial for optimizing cancer treatment strategies.
More Related Videos
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Improving Translational Accuracy
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
What is Cell Signaling?

